Suman Kumar Ankathi

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 102 citations · Full text

Medicine, Oncology, Chemotherapy +11

Minimally invasive <i>versus</i> open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes

Mufaddal Kazi, Naveena A. N. Kumar, Jitender Rohila et al. · BJS Open · 2021 · 40 citations · Full text

Medicine, Perioperative Medicine, Surgery +14

Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)

Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava et al. · Journal of Clinical Oncology · 2023 · 34 citations

Medicine, Oncology, Pharmacology +17

Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center

Anne Thomas, Neha Mittal, Swapnil Rane et al. · Head and Neck Pathology · 2021 · 33 citations · Full text

Medicine, Oncology, Surgery +17

Learning curve analysis for lateral pelvic lymph node dissection in rectal cancers – Outcomes improve with experience

Vivek Sukumar, Mufaddal Kazi, Jayesh Gori et al. · European Journal of Surgical Oncology · 2021 · 20 citations

Medicine, Oncology, Surgery +15